Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
ATCC HEL 92.1.7 (ATCC TIB-180) Human Erythroleukemia Cell Line, Suspension Culture
Supplier: ATCC HEL92.1.7
HEL 92.1.7 (ATCC TIB-180) is a human erythroleukemia cell line derived from bone marrow and used for immunology and hematopoietic research. The line grows in suspension and can undergo erythroid or macrophage-like differentiation under specific treatments. Maintain cultures in RPMI-1640 with 10% fetal bovine serum at 37°C and 5% CO2; store frozen vials in the vapor phase of liquid nitrogen.
- Human erythroleukemia cell line derived from bone marrow.
- Suspension growth properties suitable for hematopoietic studies.
- Grows in RPMI-1640 medium with 10% fetal bovine serum.
- Incubate at 37°C in a 5% CO2 atmosphere.
- Maintain cell density between 1 x 10^5 and 1 x 10^6 cells/mL.
- Store frozen vials in vapor-phase liquid nitrogen.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?